EMPHASIS-HF

Principal Investigator: Wilson Colucci, MD

Multi-center, randomized, double-blind, placebo-controlled study to demonstrate the safety and efficacy of the effect of eplerenone vs placebo on cardiovascular mortality and heart failure hospitalization in subjects with NYHA Class II chronic systolic heart failure

Research Coordinator:

Lorraine Keane, RN (617) 638-8060